Aayushi C. Shah

Ahmedabad, GJ 380009, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

CAR T-cell immunotherapy as the next horizon in cancer eradication: current landscape, challenges, and future directions.

CAR T-cell immunotherapy as the next horizon in cancer eradication: current landscape, challenges, and future directions.

Journal: Medical oncology (Northwood, London, England)

Published: May 18, 2025

Navigating the Landscape of Antibody Drug Conjugates: Current Trends and Future Research Prospects in Acute Myeloid Leukemia.

Navigating the Landscape of Antibody Drug Conjugates: Current Trends and Future Research Prospects in Acute Myeloid Leukemia.

Journal: Frontiers in bioscience (Elite edition)

Published: March 27, 2025

From current landscape to future horizon in stem cell therapy for tissue regeneration and wound healing: bridging the gap.

From current landscape to future horizon in stem cell therapy for tissue regeneration and wound healing: bridging the gap.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences

Published: January 16, 2025

Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects.

Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences

Published: February 25, 2024

Clinical and Microbiological Evaluation of Diode Laser and Systemic Doxycycline as an Additive to Scaling and Root Planing for Stage II and Stage III Periodontitis Patients.

Clinical and Microbiological Evaluation of Diode Laser and Systemic Doxycycline as an Additive to Scaling and Root Planing for Stage II and Stage III Periodontitis Patients.

Journal: Cureus

Published: February 14, 2024

Unlocking the therapeutic potential of antibody-drug conjugates in targeting molecular biomarkers in non-small cell lung cancer.

Unlocking the therapeutic potential of antibody-drug conjugates in targeting molecular biomarkers in non-small cell lung cancer.

Journal: Journal of the Egyptian National Cancer Institute

Published: November 27, 2023

Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers.

Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers.

Journal: Clinical Medicine Insights. Oncology

Published: October 16, 2023

The future of cancer immunotherapy: DNA vaccines leading the way.

The future of cancer immunotherapy: DNA vaccines leading the way.

Journal: Medical oncology (Northwood, London, England)

Published: April 24, 2023

Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects.

Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects.

Journal: Medical oncology (Northwood, London, England)

Published: February 21, 2023

Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects.

Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects.

Journal: Medical oncology (Northwood, London, England)

Published: November 03, 2022

Unveiling the antibody-drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon.

Unveiling the antibody-drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon.

Journal: Medical oncology (Northwood, London, England)

Published: October 14, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026